Published by Coherent Market Insights
Posted on September 20, 2021
Coherent Market Insights released a new market study on 2021-2027 Organ Transplant Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Organ Transplant Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/838
North America is expected to lead the global organ transplant market and this is because this region accounted for the strong presence of the healthcare industry in the region. Also, the high burden of chronic disease in the region which is increasing the prevalence of organ failure is again projected to propel the regional market growth. According to National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country.
The increasing incidence of organ failure around the globe is expanding the global organ transplant market size. Organ failure may occur due to various health conditions such as serious trauma, poisoning, loss of blood, drug abuse, sepsis, leukemia, and other acute diseases. According to The Regents of the University of California, nearly 750,000 patients per year in the United States and an estimated 2 million patients worldwide are affected by kidney failure. More than 100,000 patients in the United States are on the kidney transplant list. The growing geriatric population is increasing the prevalence of the chronic disease. This is further projected to augment the growth of the organ transplant market.
In September 2019, QBE North America, an integrated specialist insurer has announced the launch of an enhanced Organ Transplant (OT) product, designed to provide policyholders with nationwide access to transplant Centers of Excellence and Transplant Nurse Navigators
In September 2020, Natera, Inc. a provider of cell-free DNA, announced an expansive program to improve care for organ transplant patients with a history of cancer, using the Signatera
test for molecular residual disease (MRD) assessment pre-and post-transplant, in combination with the Prospera test for transplant rejection assessment
In December 2020, (PTI) Drug firm Lupin announced the launch of Mycophenolate Mofetil tablets, used to help prevent the body from rejecting organ transplants, in the US.
Organ Transplant is a major medical procedure where an organ, usually a lung or a kidney, is taken out of one human body and put into the body of another human, to replace a missing or damaged organ. The donor and recipient can usually be in the same room, or organs can be transported between donor sites to another site. The lungs, stomach, liver, heart, intestines, and kidneys are the common transplant areas. The Spicer score is one of the most commonly used metrics in assessing whether a patient is a suitable candidate for an organ transplant.
Organ Transplant Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Organogenesis Incorporated, Terumo Co., OrganOX, Transplant Biomedical, Preservation solution, TransMedic, WorldHeart Co., Waters Medical systems, and Jarvik Heart Incorporated.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/838
Reasons to Purchase this Report
• Current and future of global Organ Transplant Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Organ Transplant Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/838
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Organ Transplant Market – Increasing number of population suffering from organ failure is driving the growth of organ transplant market appeared first on Gatorledger.
Coherent Market Insights released a new market study on 2021-2027 Organ Transplant Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Organ Transplant Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/838
North America is expected to lead the global organ transplant market and this is because this region accounted for the strong presence of the healthcare industry in the region. Also, the high burden of chronic disease in the region which is increasing the prevalence of organ failure is again projected to propel the regional market growth. According to National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country.
The increasing incidence of organ failure around the globe is expanding the global organ transplant market size. Organ failure may occur due to various health conditions such as serious trauma, poisoning, loss of blood, drug abuse, sepsis, leukemia, and other acute diseases. According to The Regents of the University of California, nearly 750,000 patients per year in the United States and an estimated 2 million patients worldwide are affected by kidney failure. More than 100,000 patients in the United States are on the kidney transplant list. The growing geriatric population is increasing the prevalence of the chronic disease. This is further projected to augment the growth of the organ transplant market.
In September 2019, QBE North America, an integrated specialist insurer has announced the launch of an enhanced Organ Transplant (OT) product, designed to provide policyholders with nationwide access to transplant Centers of Excellence and Transplant Nurse Navigators
In September 2020, Natera, Inc. a provider of cell-free DNA, announced an expansive program to improve care for organ transplant patients with a history of cancer, using the Signatera test for molecular residual disease (MRD) assessment pre-and post-transplant, in combination with the Prospera test for transplant rejection assessment
In December 2020, (PTI) Drug firm Lupin announced the launch of Mycophenolate Mofetil tablets, used to help prevent the body from rejecting organ transplants, in the US.
Organ Transplant is a major medical procedure where an organ, usually a lung or a kidney, is taken out of one human body and put into the body of another human, to replace a missing or damaged organ. The donor and recipient can usually be in the same room, or organs can be transported between donor sites to another site. The lungs, stomach, liver, heart, intestines, and kidneys are the common transplant areas. The Spicer score is one of the most commonly used metrics in assessing whether a patient is a suitable candidate for an organ transplant.
Organ Transplant Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Organogenesis Incorporated, Terumo Co., OrganOX, Transplant Biomedical, Preservation solution, TransMedic, WorldHeart Co., Waters Medical systems, and Jarvik Heart Incorporated.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/838
Reasons to Purchase this Report
• Current and future of global Organ Transplant Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Organ Transplant Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/838
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Organ Transplant Market – Increasing number of population suffering from organ failure is driving the growth of organ transplant market appeared first on Gatorledger.
Explore more articles in the Research Reports category
